Clinical Trials in the UK / NCT07229027
Recruiting
Observational
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
NCT07229027 · tracked via the Priya Life Science UK tracker
Condition(s) studied
Overweight (BMI > 25)Obesity & Overweight
Study summary
We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.
Eligibility
Inclusion Criteria:
* Patient group
1. Patient is aged ≥18 years at the time of survey completion.
2. Patient has a BMI over 25 (self-reported)
3. Patient is willing to participate in all study activities.
4. Patient is able to read, write, and converse in English.
* Healthcare professional participant must meet the following criteria for inclusion in the study:
1. HCP is aged ≥18 years at the time of survey completion.
2. HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25
3. HCP is willing to participate in all study activities.
4. HCP is able to read, write, and converse in English.
Exclusion Criteria:
A participant who meets any of the following criteria will be excluded from the study:
1. Participants do not have the cognitive capacity to provide informed consent.
2. Participants with severe co-morbidity that might affect study participation.
Primary outcome measure(s)
- Development of a Disease-Specific Questionnaire — 2 months
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Online recruitment | Milton Keynes | United Kingdom | Recruiting |
More Medialis Ltd. trials in the UK
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07229027 on ClinicalTrials.gov ↗ ← All trials in the UK